Regeneron Pharmaceuticals Inc (REGN)

Receivables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 13,044,200 13,025,200 12,601,200 12,306,100 12,113,500 13,654,100 14,171,800 16,451,800 16,014,400 13,499,700 12,328,800 9,147,000 8,455,000 8,201,600 7,974,500 7,957,900 7,839,900 7,598,200 7,213,600 6,889,000
Receivables US$ in thousands 5,667,300 5,584,500 5,121,300 5,118,600 5,328,700 5,548,300 5,161,400 4,839,000 6,036,500 5,452,000 6,998,600 4,173,000 3,111,500 3,553,300 2,380,200 2,531,400 2,360,600 2,373,100 2,172,200 2,016,000
Receivables turnover 2.30 2.33 2.46 2.40 2.27 2.46 2.75 3.40 2.65 2.48 1.76 2.19 2.72 2.31 3.35 3.14 3.32 3.20 3.32 3.42

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $13,044,200K ÷ $5,667,300K
= 2.30

Regeneron Pharmaceuticals, Inc.'s receivables turnover has fluctuated over the past eight quarters, ranging from a low of 2.28 in Q4 2022 to a high of 3.41 in Q1 2022. The average receivables turnover ratio over this period is approximately 2.64.

A lower receivables turnover ratio indicates that the company is taking longer to collect payments from its customers, which could be a potential concern regarding the company's liquidity and its ability to manage its receivables effectively. Conversely, a higher ratio suggests that Regeneron Pharmaceuticals is collecting payments more efficiently.

The declining trend in the receivables turnover ratio from Q1 2022 to Q4 2023 may raise questions about the company's credit policies, customer payment behaviors, or potential issues with accounts receivable management. It is important for analysts to further investigate the reasons behind these fluctuations to assess the overall effectiveness of Regeneron Pharmaceuticals' receivables management strategy.


Peer comparison

Dec 31, 2023


See also:

Regeneron Pharmaceuticals Inc Receivables Turnover (Quarterly Data)